Emersoft Launches First Complete Commerce Solution for Online and Brick-and-Mortar Bookstores
Shan News Network
Today at 10:40pm UTC
New Jersey American Water Files Rate Request Driven by More Than $1.4 Billion in Ongoing Investment to Provide Safe, Clean, Reliable and...
PR Newswire
Today at 9:07pm UTC
MillerKnoll Appoints Former J. Jill CEO Claire Spofford to Board of Directors
PR Newswire
Today at 9:05pm UTC
Avista files four-year rate plan in Washington to support reliable service and maintain critical infrastructure
GlobeNewswire
Today at 9:05pm UTC
PEOPLES BANCORP INC. ANNOUNCES RETIREMENT OF DOUGLAS V. WYATT; RON J. MAJKA APPOINTED CHIEF COMMERCIAL BANKING OFFICER
PR Newswire
Today at 9:05pm UTC
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Today at 9:05pm UTC
Rosen Law Firm Encourages Balancer Investors to Inquire About Securities Class Action Investigation - BAL
PR Newswire
Today at 9:05pm UTC
Arteris Announces New Employment Inducement Grants
GlobeNewswire
Today at 9:05pm UTC
Heritage Financial Corporation Declares Quarterly Dividend
PR Newswire
Today at 9:05pm UTC
Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters
GlobeNewswire
Today at 9:05pm UTC
Hain Celestial Announces Fiscal 2026 Second Quarter Earnings Results Conference Call and Webcast
GlobeNewswire
Today at 9:05pm UTC
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Today at 9:05pm UTC
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Today at 9:05pm UTC
Award-Winning Virtuoso Advisor Unveils New Era of Luxury African Safaris for 2026
GlobeNewswire
Today at 9:04pm UTC
SANMINA CORPORATION INVITES YOU TO JOIN ITS FIRST QUARTER FISCAL 2026 EARNINGS CONFERENCE CALL
PR Newswire
Today at 9:01pm UTC
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
PR Newswire
Today at 9:01pm UTC
Hingham Savings Reports 2025 Results
GlobeNewswire
Today at 9:01pm UTC
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
GlobeNewswire
Today at 9:01pm UTC
Feeups - The Digital Powerhouse of Pioneering a Global Revolution in Social Connectivity and Earning.
Shan News Network
Today at 9:00pm UTC
International Paper Declares Quarterly Dividend
PR Newswire
Today at 9:00pm UTC